Overview BHV-7000 Open-Label Extension Bipolar Mania Study Status: TERMINATED Trial end date: 2025-04-25 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.Phase: PHASE2 Details Lead Sponsor: Biohaven Therapeutics Ltd.